ArticleAnnals of the American Thoracic Society2026
Phrenic nerve stimulation enhances upper airway patency during drug-induced sleep endoscopy in obstructive sleep apnea.
Article in Annals of the American Thoracic Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Commented on by
Authors and funding
8 authors.
Funding
Abstract
rationaleObstructive sleep apnea (OSA) is characterized by recurrent upper airway (UA) collapse during sleep. Continuous positive airway pressure (CPAP) is an effective but often poorly tolerated treatment. Neurostimulation targeting UA dilators has emerged as an alternative therapy, though coordinating stimulation of multiple effector muscles may be challenging. Phrenic nerve stimulation (PNS) offers a potential alternative that may engage both efferent and afferent respiratory mechanisms to enhance airway patency.
objectiveTo examine how PNS timing affects UA patency in OSA patients undergoing drug-induced sleep endoscopy.
methodsObstructive sleep apnea patients underwent drug-induced sleep endoscopy. Subtherapeutic CPAP was applied to maintain stable flow-limited breathing for PNS experiments. Transcutaneous PNS was delivered via a cervical electrode at different phases of respiration: end-expiration to inspiration (E→I), inspiration only (I→I), and mid-inspiration to expiration (I→E). Sequential stimulations were also performed at E→I to observe sustained effects. Effect of stimulation on inspiratory flow (VI), tidal volume (TV), and minute ventilation (MV) were quantified using mixed-effects models. MEASUREMENTS AND MAIN
resultsA total of 19 patients participated: 13 completed both isolated and sequential protocols, and 6 completed only the sequential protocol. Isolated PNS timed to E→I increased VI (64%) and TV (71%) compared with baseline. Sequential PNS at E→I produced sustained improvements with further increases in VI (171%), TV (173%), and MV (169%).
conclusionsPhrenic nerve stimulation delivered at end-expiration significantly improved UA patency and ventilation, with sequential stimulation further potentiating these effects. Phase-locked PNS responses implicate underlying neural afferent mechanisms and suggest novel PNS strategies for treating OSA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.